Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 969 | 591 | 1,466 | 731 | 1,126 |
| Cost of Goods | 707 | 716 | 945 | 618 | 585 |
| Gross Profit | 262 | -125 | 521 | 113 | 541 |
| Operating Expenses | 6,550 | 7,720 | 5,054 | 5,528 | 7,350 |
| Operating Income | -5,581 | -7,129 | -3,588 | -4,797 | -6,224 |
| Interest Expense | 538 | 591 | 645 | 645 | 645 |
| Other Income | 70 | 176 | -685 | 58 | 464 |
| Pre-tax Income | -6,049 | -7,544 | -4,918 | -5,384 | -6,405 |
| Net Income Continuous | -6,049 | -7,544 | -4,918 | -5,384 | -6,405 |
| Net Income | $-6,049 | $-7,544 | $-4,918 | $-5,384 | $-6,405 |
| EPS Basic Total Ops | -36,356.82 | -0.33 | -0.18 | -0.26 | -0.43 |
| EPS Basic Continuous Ops | -36,275.87 | -0.33 | -0.17 | -0.26 | -0.43 |
| EPS Diluted Total Ops | -36,356.82 | -0.33 | -0.18 | -0.26 | -0.43 |
| EPS Diluted Continuous Ops | -36,275.87 | -0.33 | -0.17 | -0.26 | -0.43 |
| EBITDA(a) | $-4,772 | $-6,468 | $-2,960 | $-4,331 | $-5,705 |